Science Explorer Back to mapMap
Discussion
Researcher · Scholar Rock (United States) · United States

Gregory J. Carven

Gregory J. Carven publishes mostly in Immunology, Molecular Biology and Oncology, on topics such as Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research and T-cell and B-cell Immunology.

ORCID 0000-0002-8468-6323 OpenAlex
World rank
#1,249,316
of 7,710,434 ranked researchers
Rank in United States
#399,029
of 1,627,098
Works
24
Citations
1.5k
Citations per work
64.5
h-index
14
i10-index 14Top 52% in Immunology
Gregory J. Carven

What does Gregory J. Carven research?

Gregory J. Carven's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (23%), Immunology and Microbiology (21%).

Life Sciences: 11 works · 44.3% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 23.0% of their workMolecular Biology: 5 works · 19.7% of their workBiotechnology: 1 works · 3.3% of their workImmunology and Microbiology: 5 works · 21.3% of their workImmunology: 5 works · 21.3% of their workHealth Sciences: 8 works · 32.8% of their workMedicine: 8 works · 32.8% of their workOncology: 5 works · 19.7% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 8.2% of their workCardiology and Cardiovascular Medicine: 1 works · 4.9% of their workEverything else: 5 works · 22.9% of their workTHEIR WORKGregory J. Carven24works
Life Sciences44%Health Sciences33%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology623.0%
    2. Immunology and Microbiology521.3%
    1. Medicine832.8%
  3. Everything else522.9%
  1. 1Immunology21% of their works
  2. 2Molecular Biology20% of their works
  3. 3Oncology20% of their works
  4. 4Radiology, Nuclear Medicine and Imaging8% of their works
  5. 5Cardiology and Cardiovascular Medicine5% of their works
  6. 6Biotechnology3% of their works

Research topics

Which keywords describe Gregory J. Carven's research?

The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Dendritic Cells, Immunity, Antibody Engineering, Fc Receptors, Foxp3 and Immune Checkpoint Blockade.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Monoclonal Antibodies72 topics
  2. Therapeutic Antibodies72 topics
  3. Dendritic Cells61 topic
  4. Immunity61 topic
  5. Antibody Engineering51 topic
  6. Fc Receptors51 topic
  7. Foxp341 topic
  8. Immune Checkpoint Blockade41 topic
  9. PD-1 and PD-L141 topic
  10. TGF-ß41 topic
  11. Cardiomyopathies31 topic
  12. Genetic Mutations31 topic
  13. Muscle Regeneration31 topic
  14. Skeletal Muscle Atrophy31 topic
  15. Biopharmaceuticals21 topic
  16. Cancer Genomics21 topic
  17. Mutational Signatures21 topic
  18. Protein Aggregation21 topic

Where does Gregory J. Carven work?

Gregory J. Carven's main affiliation in the publication record is Scholar Rock (United States), United States.

How many publications and citations does Gregory J. Carven have?

OpenAlex counts 24 works and 1,547 citations for Gregory J. Carven, an h-index of 14, ranking #1,249,316 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Gregory J. Carven. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.